|
|
|
Volumn 35, Issue 7, 2011, Pages 28-33
|
|
FDA and manufacturers ponder biosimilars pathway
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COMPLEX BIOLOGICS;
PRODUCT DEVELOPMENT;
BIOLOGICAL FACTOR;
GENERIC DRUG;
ARTICLE;
AUTHORITY;
BIOLOGICAL THERAPY;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG MANUFACTURE;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INVESTMENT;
LAW;
LICENCE;
POLICY;
PRODUCT DEVELOPMENT;
PRODUCT PARAMETERS;
PRODUCT SAFETY;
TIME;
|
|
EID: 80051888271
PISSN: 15432521
EISSN: 21507376
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
